Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Cirrhosis, a final pathway for a wide variety of chronic liver diseases ( Box 74.1 ), is a pathologic entity defined as diffuse hepatic fibrosis with the replacement of the normal liver architecture by nodules. The rate of progression of chronic liver disease to cirrhosis may be quite variable, from weeks in patients with complete biliary obstruction to decades in patients with chronic hepatitis C. Cirrhosis is one of the leading causes of mortality in the USA and particularly afflicts persons in the most productive years of their lives. Acute-on-chronic liver failure (ACLF) is also discussed in this chapter, and the protean complications of cirrhosis ( Box 74.2 ) are discussed in other chapters (see Chapter 21, Chapter 92, Chapter 93, Chapter 94 and 96 ).
HBV
HCV
HDV
Autoimmune hepatitis
PBC
PSC
Alcohol
Arsenic
α 1 Antitrypsin deficiency
Galactosemia
Glycogen storage disease
Hemochromatosis
NAFLD and NASH
Wilson disease
Atresia
Stone
Tumor
Budd-Chiari syndrome
Cardiac fibrosis
CF
Lysosomal acid lipase deficiency
Biliary injury
Drugs: high-dose vitamin A, methotrexate
Ascites
Variceal bleeding
Cholangiocarcinoma
HCC
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here